Bank of America’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-163,226
| Closed | -$555K | – | 7644 |
|
|
2018
Q3 | $555K | Sell |
163,226
-128,830
| -44% | -$464K | ﹤0.01% | 4870 |
|
|
2018
Q2 | $1.1M | Buy |
292,056
+106,737
| +58% | +$520K | ﹤0.01% | 4410 |
|
|
2018
Q1 | $758K | Sell |
185,319
-12,893
| -7% | -$60K | ﹤0.01% | 4563 |
|
|
2017
Q4 | $921K | Buy |
198,212
+83,507
| +73% | +$460K | ﹤0.01% | 4542 |
|
|
2017
Q3 | $815K | Buy |
114,705
+19,493
| +20% | +$140K | ﹤0.01% | 4638 |
|
|
2017
Q2 | $688K | Sell |
95,212
-13,346
| -12% | -$83.4K | ﹤0.01% | 4685 |
|
|
2017
Q1 | $669K | Sell |
108,558
-22,042
| -17% | -$121K | ﹤0.01% | 4694 |
|
|
2016
Q4 | $765K | Buy |
130,600
+7,086
| +6% | +$38.7K | ﹤0.01% | 4522 |
|
|
2016
Q3 | $656K | Sell |
123,514
-10,918
| -8% | -$58.9K | ﹤0.01% | 4439 |
|
|
2016
Q2 | $890K | Buy |
134,432
+13,794
| +11% | +$77.1K | ﹤0.01% | 4264 |
|
|
2016
Q1 | $563K | Sell |
120,638
-255,812
| -68% | -$1.02M | ﹤0.01% | 4525 |
|
|
2015
Q4 | $1.9M | Sell |
376,450
-286,545
| -43% | -$1.36M | ﹤0.01% | 3843 |
|
|
2015
Q3 | $2.33M | Buy |
662,995
+463,282
| +232% | +$3.1M | ﹤0.01% | 3612 |
|
|
2015
Q2 | $1.99M | Buy |
199,713
+71,883
| +56% | +$771K | ﹤0.01% | 3460 |
|
|
2015
Q1 | $1.63M | Buy |
127,830
+58,354
| +84% | +$750K | ﹤0.01% | 3407 |
|
|
2014
Q4 | $983K | Sell |
69,476
-230,689
| -77% | -$3.57M | ﹤0.01% | 4054 |
|
|
2014
Q3 | $4.13M | Buy |
300,165
+155,640
| +108% | +$2.38M | ﹤0.01% | 2752 |
|
|
2014
Q2 | $2.22M | Buy |
144,525
+48,352
| +50% | +$685K | ﹤0.01% | 3270 |
|
|
2014
Q1 | $1.64M | Sell |
96,173
-21,755
| -18% | -$328K | ﹤0.01% | 3400 |
|
|
2013
Q4 | $1.53M | Buy |
117,928
+37,423
| +46% | +$447K | ﹤0.01% | 3603 |
|
|
2013
Q3 | $813K | Sell |
80,505
-10,822
| -12% | -$96.3K | ﹤0.01% | 4155 |
|
|
2013
Q2 | $682K | Buy |
+91,327
| New | +$714K | ﹤0.01% | 4440 |
|
Bank of America's KERX Position: Q4 2018 in Review
Bank of America sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 163,226 shares — an estimated $555K sold.
Bank of America first reported a position in KERX in Q2 2013 and held it in 22 quarters. The position peaked at $4.13M in Q3 2014. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.
- Bank of America reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
- Bank of America sold 163,226 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $555K.
- Bank of America first reported a position in Keryx Biopharmaceuticals Inc in Q2 2013 and held it in 22 quarters.
- Bank of America's Keryx Biopharmaceuticals Inc position peaked at $4.13M in Q3 2014.
- 1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.
Based on Bank of America's 13F filing for Q4 2018, filed 14 Feb 2019.